75%Confidence
0Views
FDASource
2026-04-05Date
Summary
Defective blister packaging for Midodrine Hydrochloride Tablets suggests packaging process failures that could compromise product integrity and patient safety. This may result in supply chain disruptions for this blood pressure medication and increased regulatory scrutiny for The Harvard Drug Group.
Actionable: Verify packaging integrity for all blister-packed medications from this manufacturer and consider temporary alternative sourcing.
AI Confidence: 75%
Data Points
firmThe Harvard Drug Group LLC
classificationClass II
statusOngoing
distributionNationwide US.
productMidodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapol
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now